Humoral Immune Response of SARS‐CoV ‐2–Infected Patients with Cancer: Influencing Factors and Mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Humoral Immune Response of
SARS‐CoV
‐2–Infected Patients with Cancer: Influencing Factors and Mechanisms
Authors
Keywords
-
Journal
ONCOLOGIST
Volume 26, Issue 9, Pages -
Publisher
Wiley
Online
2021-05-21
DOI
10.1002/onco.13828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
- (2020) Hongzhou Lu et al. JOURNAL OF MEDICAL VIROLOGY
- Risk of COVID-19 for cancer patients
- (2020) Yang Xia et al. LANCET ONCOLOGY
- Risk of COVID-19 for patients with cancer
- (2020) Hanping Wang et al. LANCET ONCOLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
- (2020) H. Miyashita et al. ANNALS OF ONCOLOGY
- Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
- (2020) M.L. Solodky et al. ANNALS OF ONCOLOGY
- Facing SARS-CoV-2 outbreak in immunotherapy era
- (2020) Fabrizio Citarella et al. Future Oncology
- The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review
- (2020) Victor E. Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The many faces of the anti-COVID immune response
- (2020) Santosha A. Vardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
- (2020) Breanna M. Allen et al. NATURE MEDICINE
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- (2020) Vikas Mehta et al. Cancer Discovery
- Low prevalence of IgG antibodies to SARS‐CoV ‐2 in cancer patients with COVID ‐19
- (2020) Tao Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
- (2020) Silvia Vivarelli et al. Cancers
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- (2020) Dimple Chakravarty et al. Communications Biology
- Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2
- (2020) Antonio Marra et al. ANNALS OF ONCOLOGY
- Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset
- (2020) Patrícia Figueiredo‐Campos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
- (2020) Géraldine Descamps et al. Biology-Basel
- The B-side of Cancer Immunity: The Underrated Tune
- (2019) Largeot et al. Cells
- Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
- (2019) Carin A. T. C. Lunenburg et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition
- (2017) Xiaoguang Wang et al. HAEMATOLOGICA
- Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy
- (2017) Meghali Goswami et al. Journal of Translational Medicine
- Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition
- (2017) Xiaoguang Wang et al. HAEMATOLOGICA
- Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
- (2016) Vishwajith Sridharan et al. BRITISH JOURNAL OF CANCER
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Oxaliplatin-induced immune-mediated cytopenias: A case report and literature review
- (2014) Nicholas P Forcello et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG
- (2013) M Fiegl et al. LEUKEMIA
- Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials
- (2011) Fabio A.B. Schutz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Oxaliplatin: a review in the era of molecularly targeted therapy
- (2011) T. Alcindor et al. Current Oncology
- Paclitaxel and immune system
- (2009) Aqeel Javeed et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started